Senior Global Access Evidence Leader - HTA Statistician

Roche; Basel; Vor Ort; CHF 180.000 - 260.000; Vollzeit

Zusammenfassung

Roche is seeking a Senior Global Access Evidence Leader to drive EU HTA submissions and evidence strategies. You will lead complex analyses, shape region-specific evidence packages, and collaborate with European payers and EMA committees to secure patient access across EU markets.

The role requires extensive EU HTA experience, advanced statistics skills, and strong cross-functional leadership to influence European health technology assessments and reimbursement decisions.

Qualifikationen

• Advanced expertise in EU HTA and regulatory submissions.
• Experience with EMA processes and national HTA requirements.
• Strong leadership and communication in cross-functional EU teams.

Aufgaben

• Lead EU HTA evidence strategy for submissions.
• Drive methodological innovation across EU contexts.
• Architect region-specific evidence packages for EMA committees and national payers.
• Establish Roche as an EU HTA expert through engagement with HTA bodies.
• Lead statistical analyses (NMA, real-world evidence) and translate findings into narratives.
• Mentor affiliates and cross-functional teams on EU regulatory and HTA landscape.

Kenntnisse

EU HTA expertise

12+ years experience

Statistics in pharma

Strategic thinking

English proficiency

Ausbildung

Master's or Doctoral degree in applied statistics

Tools

R

GitLab

SAS

Python

Jobbeschreibung

At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters.

The Position

Our Global Pharma Strategy (GPS) team plays a pivotal role in shaping the future of healthcare by driving the strategic direction of our innovative product portfolio. As a member of the GPS team, you will be at the forefront of transforming groundbreaking scientific discoveries into accessible and impactful healthcare solutions for patients worldwide. We are seeking a dynamic and visionary senior professional who thrives in a collaborative environment and is passionate about making a difference.

Role Overview

We are seeking a dynamic and visionary Senior Global Access Evidence Leader with deep EU HTA and advanced statistical and evidence-synthesis expertise to join our Evidence Chapter—a professional recognized within the European HTA community for advancing evidence standards and shaping submissions that secure patient access across EU member states. In this role, you will thrive in a collaborative environment and be passionate about making a difference.

The Opportunity

• Lead EU HTA evidence strategy: Shape Roche's approach to EU HTA submissions by embedding sophisticated, anticipatory evidence strategies into clinical development from inception, ensuring alignment with EMA regulations, and the new EU HTA regulations. Position us as a benchmark for evidence excellence across European markets
• Drive methodological innovation in EU contexts: Leverage your established networks within European HTA bodies, payers, and health authorities to advance evidence standards and best practices—influencing how the industry approaches submissions to national HTA organizations and contributing to the evolution of EU HTA frameworks
• Architect compelling EU submissions: Design innovative, region‑specific evidence packages that anticipate the needs of EMA committees, HTA bodies and national payers. Identify strategic evidence gaps early, pioneer novel data sources and analyses, and translate complex statistical findings into narratives that drive reimbursement and access decisions across EU markets
• Establish Roche as an EU HTA expert: Leverage your reputation and deep relationships within the European Access/HTA ecosystem to elevate submission quality, engage proactively with key opinion leaders and HTA bodies, and position Roche as a thought leader in EU evidence generation and submission strategy
• Lead strategic statistical analysis for EU evidence packages: Lead and critically evaluate complex statistical analyses—including network meta‑analyses and real‑world evidence syntheses—ensuring methodological rigor and compliance with EU HTA requirements while translating findings into compelling, region‑appropriate narratives
• Enable affiliates and cross‑functional teams: Guide European affiliate teams and cross‑functional partners in building robust EU submission strategies, ensure alignment across EMA development pathways and national HTA submissions, and mentor colleagues on evolving EU regulatory and HTA landscapes
• Contribute to EU HTA evolution: Maintain influential engagement with European HTA bodies, regulatory agencies, and academic networks—actively participating in professional forums, contributing to methodological debates, and ensuring Roche remains at the forefront of EU evidence standards and innovation

Who You Are

• Advanced expertise & experience in EU HTA: You hold a Master's or Doctoral‑level degree in applied statistics and bring 12+ years of deep, hands‑on experience in the pharmaceutical industry, health economics/HTA consultancy, European payer organizations, EMA‑regulated environments, or academic research with progressive strategic influence in European markets
• Recognized standing in the European HTA community: You are a known voice actively engaged with European HTA networks, national HTA bodies, or equivalent professional networks, holding established relationships with key opinion leaders and contributing to methodological discussions through publications, conference presentations, or advisory roles
• Deep knowledge of the EU HTA landscape: You demonstrate a thorough understanding of the EU HTA Regulation (2021/2282) and joint clinical assessment procedures, national HTA requirements across major European markets (UK, Germany, France, Italy, Spain, etc.), EMA scientific advice and conditional approval pathways, and real‑world evidence requirements in EU contexts
• Master‑level statistical expertise & strategic vision: You possess mastery of advanced statistical methods (Generalized Linear Models, Survival Analysis, Network Meta‑Analysis, Bayesian methods, real‑world evidence analyses) using R and contemporary tools (GitLab, SAS, Python, WinBUGS, JAGS), paired with the ability to think strategically about EU market access and nuances across European healthcare systems
• Collaborative leadership & exceptional communication: You excel at leading cross‑functional teams in matrix environments, engaging with European affiliate teams and external HTA bodies, and possess outstanding written and verbal communication skills in English (and ideally German, French, or other European languages) to translate technical analyses into compelling narratives

Who we are

A healthier future drives us to innovate. Together, more than 100’000 employees across the globe are dedicated to advance science, ensuring everyone has access to healthcare today and for generations to come. Our efforts result in more than 26 million people treated with our medicines and over 30 billion tests conducted using our Diagnostics products. We empower each other to explore new possibilities, foster creativity, and keep our ambitions high, so we can deliver life‑changing healthcare solutions that make a global impact. Let’s build a healthier future, together.

Roche is an Equal Opportunity Employer.